We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
The European Trade Mark and Design Network has updated its common practice on the general indications of the Nice classification headings in accordance with European Union Trade Mark Regulation No. 2015/2424.
The European Trade Mark and Design Network has updated its common practice on the general indications of the Nice classification headings. This is in accordance with the Nice Classification List (10 -2016).
Guidelines on the acceptance of pleas and the prosecutor's role in the sentencing exercise (revised 2009).
Guidance for businesses and organisations on the relationship between trade marks and geographical indications (GIs) at the end of the transition period.
How to apply for a traditional herbal registration (THR) to market a herbal medicine in the UK.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
Use a separate statement of objection form for each Japanese GI product name you object to.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Find out about the Spirit Drinks Verification Scheme if you produce a UK spirit drink with a protected Geographical Indication.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
What you need to do to place a medical device on the Great Britain, Northern Ireland and European Union (EU) markets.
The MHRA will review applications for orphan designation at the time of a marketing authorisation (MA) or variation application.
Apply for a promising innovative medicine (PIM) designation or scientific opinion for your medicine from MHRA.
Guidance providing practical information for placing construction products on the Northern Ireland market and unfettered access provisions.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Find out about applying for the Spirit Drinks Verification Scheme, how to submit brand information, fees and making sure your production process is compliant.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).